Comment Other Accident Details Raise Questions (Score 1) 485
First off, it seems to me that driving on an experimental 'autpilot' in a roadway that has intersections (as is shown in the police report figure in: ( http://www.nytimes.com/2016/07... ) is tremendously more dangerous than using it on an interstate. That, and the reported presence of a dvd player causes one to question the drivers decision making.
But a greater concern, at least for me, is that the truck appears to have turned right in front of the Tesla. One possibility there is that the intersection had traffic lights, whose detection was missed by both driver and computer, which if true, is a bigger concern than missing the side of a white truck on a bright background. The other is that the truck did not yield to the oncoming car when making its turn, that is the truck cut off the tesla in the intersection. Apart from the liability issues raised, that circumstance is much more difficult to react to, either in person or by computer.
Any one have any further info?
Comment Been there, done that... (Score 1) 162
Of course when we do that demo, we stand on a 2 inch plexiglass plate, which sits on top of a couple of 4x4's. Turns out (not suprisingly) that the discharge part is much more risky than the charging. I have a student turn off the machine, which I'm still holding onto, and wait 30 seconds. The machine is then discharged by touching to ground. That give me a bit of a jolt, but if its done too soon -- IT REALLY HURTS!!
With the discharge event being an important part of this process, its not something I would willingly undergo....
Comment Re:Better information (Score 1) 217
Abstract
The actin cytoskeleton is a potentially vulnerable property of cancer cells, yet chemotherapeutic targeting attempts have been hampered by unacceptable toxicity. In this study, we have shown that it is possible to disrupt specific actin filament populations by targeting isoforms of tropomyosin, a core component of actin filaments, that are selectively upregulated in cancers. A novel class of anti-tropomyosin compounds has been developed that preferentially disrupts the actin cytoskeleton of tumor cells, impairing both tumor cell motility and viability. Our lead compound, TR100, is effective in vitro and in vivo in reducing tumor cell growth in neuroblastoma and melanoma models. Importantly, TR100 shows no adverse impact on cardiac structure and function, which is the major side effect of current anti-actin drugs. This proof-of-principle study shows that it is possible to target specific actin filament populations fundamental to tumor cell viability based on their tropomyosin isoform composition. This improvement in specificity provides a pathway to the development of a novel class of anti-actin compounds for the potential treatment of a wide variety of cancers. Cancer Res; 73(16); 5169–82. 2013 AACR.
Comment Better information (Score 2) 217
http://cancerres.aacrjournals.org/content/73/16/5169.full.pdf+html
It was published yesterday...
Submission + - Large Sheets of Carbon Nanotubes Produced (nextbigfuture.com)
Submission + - SPAM: Mozilla opens Thunderbird e-mail subsidiary
Link to Original Source
Male Brains 'Wired for Videogame Obsession' 125
Submission + - Trial set to determine what SCO owes Novell (networkworld.com)
Feed Engadget: Prosthetic-limbed runner disqualified from Olympics (engadget.com)
Filed under: Misc. Gadgets
Oscar Pistorius, a double-amputee sprinter, has been denied a shot at the Olympics... for being too fast. The runner -- who uses carbon-fiber, prosthetic feet -- was reviewed by the International Association of Athletics Federations (or IAAF), a review which found the combination of man and machine to be too much for its purely human competitors. According to the IAAF report, the "mechanical advantage of the blade in relation to the healthy ankle joint of an able bodied athlete is higher than 30-percent." Additionally, Pistorius uses 25-percent less energy than average runners due to the artificial limbs, therefore giving him an unfair advantage on the track... or so they say. Oscar is expected to appeal the decision, saying a lack of variables explored by the single scientific study calls for deeper investigation into the matter. Our suggestion? Prosthetic legs for all![Via Medgadget]
Read | Permalink | Email this | Comments
Feed Science Daily: Mothers' Stress May Increase Children's Asthma (sciencedaily.com)
Feed Techdirt: EFF Busts Yet Another Bogus Patent... But It's Taking A Long Time (techdirt.com)
While it's great to see the EFF busting patents, one of the things the EFF has really highlighted here is how incredibly difficult it is to bust bogus patents. We've had patent attorneys tell us that busting patents is easy, yet, here we are three-and-a-half years into the process and the EFF has only been able to get the USPTO to re-examine three of the ten patents. Even on this particular patent, the original re-exam was granted over a year-and-a-half ago, and the rejection has just come down. During all that time, Test.com was free to accuse anyone of violating its patent, potentially scaring off many companies (and universities) from being able to offer something as simple and obvious as online testing.
Permalink | Comments | Email This Story